Extracorporeal membrane oxygenation for XXXX in Japan.

@entity1 @entity101 @entity7195 @entity894 @entity2914 @entity2008 @entity6926
OBJECTIVE: The aim of this study was to clarify how extracorporeal membrane oxygenation (ECMO) is used to treatcongenital @entity2914 ( @entity7195 ) in Japan. METHODS: We completed a nationwide survey of @entity7195 involving 614 @entity1 . The subjects of this study included 43 @entity1 who underwent ECMO. We compared the clinical data ofthe @entity1 who did and did not survive for more than 90 days, and analyzed the 24-hour blood gas data in isolated @entity7195 cases in both groups. RESULTS: Of the 43 @entity7195 @entity1 , non-isolated @entity7195 that was associated with other life-threatening or @entity2008 was diagnosed in six @entity1 .Only one of these 6 @entity1 was able to discontinue ECMO and survived, and the other 5 died shortly after birth. The other 37 cases all had isolated @entity7195 . The reason for initiating ECMO in 31 of these cases was persistent pulmonary @entity101 of the newborn (PPHN). In the 37 cases with isolated @entity7195 , ECMO was initiated within 24 hours after birth. Sixteen @entity1 (37%) survived for more than 90 days, and intact discharge was possiblein eight cases. Among the isolated @entity7195 @entity1 , the 90-day survival cutoff value based onthe ROC analysis @entity894 ( @entity6926 )was 15. CONCLUSIONS: ECMO is used to treat PPHN starting from an early period after birth. However, the mortality and morbidity are not favorable. The index used to predict @entity1 who will survive following ECMO shows the lowest @entity6926 of 15.
